Organon & Co.
OGN
$8.14
-$0.305-3.61%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -6.72% | -0.38% | 4.15% | -0.06% | 5.46% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.72% | -0.38% | 4.15% | -0.06% | 5.46% |
| Cost of Revenue | 1.05% | 1.90% | 7.68% | 4.38% | 14.66% |
| Gross Profit | -12.12% | -2.08% | 1.76% | -3.00% | -0.10% |
| SG&A Expenses | -2.55% | 20.93% | -21.56% | -3.10% | -0.92% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.66% | 7.48% | -7.38% | 0.16% | 5.59% |
| Operating Income | -21.50% | -24.37% | 68.10% | -0.77% | 5.08% |
| Income Before Tax | -57.20% | 24.04% | 158.75% | -7.48% | 0.43% |
| Income Tax Expenses | -60.00% | 104.52% | -790.91% | 233.33% | -39.66% |
| Earnings from Continuing Operations | -56.72% | -80.04% | 518.97% | -19.42% | 13.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -56.72% | -80.04% | 518.97% | -19.42% | 13.56% |
| EBIT | -21.50% | -24.37% | 68.10% | -0.77% | 5.08% |
| EBITDA | -14.61% | -17.40% | 56.66% | 1.12% | 6.21% |
| EPS Basic | -57.08% | -80.20% | 514.46% | -20.04% | 12.98% |
| Normalized Basic EPS | -26.16% | -39.33% | 220.14% | -2.32% | 10.37% |
| EPS Diluted | -57.69% | -80.66% | 508.20% | -20.87% | 13.04% |
| Normalized Diluted EPS | -26.30% | -39.63% | 218.36% | -2.58% | 9.99% |
| Average Basic Shares Outstanding | 0.85% | 0.81% | 0.75% | 0.76% | 0.51% |
| Average Diluted Shares Outstanding | 1.02% | 1.28% | 1.33% | 1.03% | 0.86% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 1.34% | 4.08% | -0.84% | 0.32% | -0.16% |